loganin has been researched along with Cognitive Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
He, K; Li, S; Liu, J; Nie, L; Xiao, S; Xie, F; Xu, J; Yang, C; Yang, X; Zhang, K; Zhou, L; Zou, L | 1 |
Du, G; Gao, W; Guo, Y; He, Y; Luo, D; Pang, X; Shi, J; Xie, X; Xu, W; Yang, X; Zhao, Q; Zhou, Y | 1 |
2 other study(ies) available for loganin and Cognitive Dysfunction
Article | Year |
---|---|
Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Disease Models, Animal; Female; Hippocampus; Iridoids; Mice; Mice, Transgenic; Morris Water Maze Test; Neuroprotective Agents; Proteome | 2021 |
Loganin alleviated cognitive impairment in 3×Tg-AD mice through promoting mitophagy mediated by optineurin.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Humans; Iridoids; Male; Mice; Mitophagy; Molecular Docking Simulation; Neuroblastoma; Protein Kinases; Ubiquitin-Protein Ligases | 2023 |